Journal of Hepatocellular Carcinoma
Volume 11, 2024 - Issue
REVIEW
CRISPR in Targeted Therapy and Adoptive T Cell Immunotherapy for Hepatocellular Carcinoma
Fahreddin Palaz1 Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA;2 Faculty of Medicine, Hacettepe University, Ankara, Turkey
https://orcid.org/0000-0002-9514-3172View further author information
https://orcid.org/0000-0002-9514-3172View further author information, Mehmet Ozsoz3 Department of Biomedical Engineering, Near East University, Nicosia, Turkeyhttps://orcid.org/0000-0003-4037-3445View further author information
https://orcid.org/0000-0003-4037-3445View further author information, & Ilyas Sahin5 University of Florida Health Cancer Center, Gainesville, FL, USA;6 Division of Hematology and Oncology, Department of Medicine, University of Florida, Gainesville, FL, USACorrespondence[email protected]
https://orcid.org/0000-0003-2070-9319View further author information
https://orcid.org/0000-0003-2070-9319View further author information